Figure 3.
Schematic illustration of aptamer-mediated cancer therapy. Four approaches are presented: free aptamer as chemotherapeutic agents, aptamer-drug conjugates, aptamer-nanoparticle-drug delivery system and aptamer-guided cancer gene therapy. After specific binding of aptamers to their cell surface target, aptamer-conjugated therapeutic agents (including exogenous therapeutic nucleotides) or drug-encapsulated nanoparticles are internalised into cancer cells via receptor-mediated endocytosis. Subsequent escape from endosomes and/or lysosomes enables the released therapeutic agents to eradicate cancer cell.
